The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease - PubMed (original) (raw)
Review
The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease
Hiroyuki Kobori et al. Pharmacol Rev. 2007 Sep.
Abstract
In recent years, the focus of interest on the role of the renin-angiotensin system (RAS) in the pathophysiology of hypertension and organ injury has changed to a major emphasis on the role of the local RAS in specific tissues. In the kidney, all of the RAS components are present and intrarenal angiotensin II (Ang II) is formed by independent multiple mechanisms. Proximal tubular angiotensinogen, collecting duct renin, and tubular angiotensin II type 1 (AT1) receptors are positively augmented by intrarenal Ang II. In addition to the classic RAS pathways, prorenin receptors and chymase are also involved in local Ang II formation in the kidney. Moreover, circulating Ang II is actively internalized into proximal tubular cells by AT1 receptor-dependent mechanisms. Consequently, Ang II is compartmentalized in the renal interstitial fluid and the proximal tubular compartments with much higher concentrations than those existing in the circulation. Recent evidence has also revealed that inappropriate activation of the intrarenal RAS is an important contributor to the pathogenesis of hypertension and renal injury. Thus, it is necessary to understand the mechanisms responsible for independent regulation of the intrarenal RAS. In this review, we will briefly summarize our current understanding of independent regulation of the intrarenal RAS and discuss how inappropriate activation of this system contributes to the development and maintenance of hypertension and renal injury. We will also discuss the impact of antihypertensive agents in preventing the progressive increases in the intrarenal RAS during the development of hypertension and renal injury.
Similar articles
- [Mechanisms responsible for the renoprotective effects of renin-angiotensin inhibitors].
Nishiyama A. Nishiyama A. Yakugaku Zasshi. 2012;132(4):455-9. doi: 10.1248/yakushi.132.455. Yakugaku Zasshi. 2012. PMID: 22465922 Review. Japanese. - Independent regulation of renin-angiotensin-aldosterone system in the kidney.
Nishiyama A, Kobori H. Nishiyama A, et al. Clin Exp Nephrol. 2018 Dec;22(6):1231-1239. doi: 10.1007/s10157-018-1567-1. Epub 2018 Mar 29. Clin Exp Nephrol. 2018. PMID: 29600408 Free PMC article. Review. - Role of stimulated intrarenal angiotensinogen in hypertension.
Satou R, Shao W, Navar LG. Satou R, et al. Ther Adv Cardiovasc Dis. 2015 Aug;9(4):181-90. doi: 10.1177/1753944715585512. Epub 2015 May 18. Ther Adv Cardiovasc Dis. 2015. PMID: 25987608 Free PMC article. Review. - Recent Updates on the Proximal Tubule Renin-Angiotensin System in Angiotensin II-Dependent Hypertension.
Li XC, Zhuo JL. Li XC, et al. Curr Hypertens Rep. 2016 Aug;18(8):63. doi: 10.1007/s11906-016-0668-z. Curr Hypertens Rep. 2016. PMID: 27372447 Free PMC article. Review. - Renal responses to AT1 receptor blockade.
Navar LG, Harrison-Bernard LM, Imig JD, Cervenka L, Mitchell KD. Navar LG, et al. Am J Hypertens. 2000 Jan;13(1 Pt 2):45S-54S. doi: 10.1016/s0895-7061(99)00248-4. Am J Hypertens. 2000. PMID: 10678288 Review.
Cited by
- Urinary Angiotensinogen Level Predicts AKI in Acute Decompensated Heart Failure: A Prospective, Two-Stage Study.
Yang X, Chen C, Tian J, Zha Y, Xiong Y, Sun Z, Chen P, Li J, Yang T, Ma C, Liu H, Wang X, Hou FF. Yang X, et al. J Am Soc Nephrol. 2015 Aug;26(8):2032-41. doi: 10.1681/ASN.2014040408. Epub 2015 Feb 26. J Am Soc Nephrol. 2015. PMID: 25722365 Free PMC article. - Age-related hypertension and salt sensitivity are associated with unique cortico-medullary distribution of D1R, AT1R, and NADPH-oxidase in FBN rats.
Pokkunuri I, Chugh G, Rizvi I, Asghar M. Pokkunuri I, et al. Clin Exp Hypertens. 2015;37(1):1-7. doi: 10.3109/10641963.2014.977489. Epub 2015 Jan 6. Clin Exp Hypertens. 2015. PMID: 25562528 Free PMC article. - Altered functioning of both renal dopamine D1 and angiotensin II type 1 receptors causes hypertension in old rats.
Chugh G, Lokhandwala MF, Asghar M. Chugh G, et al. Hypertension. 2012 May;59(5):1029-36. doi: 10.1161/HYPERTENSIONAHA.112.192302. Epub 2012 Mar 12. Hypertension. 2012. PMID: 22411927 Free PMC article. - The kallikrein-kinin system in diabetic nephropathy.
Tomita H, Sanford RB, Smithies O, Kakoki M. Tomita H, et al. Kidney Int. 2012 Apr;81(8):733-44. doi: 10.1038/ki.2011.499. Epub 2012 Feb 8. Kidney Int. 2012. PMID: 22318421 Free PMC article. Review. - Involvement of the intrarenal renin-angiotensin system in experimental models of glomerulonephritis.
Urushihara M, Kinoshita Y, Kondo S, Kagami S. Urushihara M, et al. J Biomed Biotechnol. 2012;2012:601786. doi: 10.1155/2012/601786. Epub 2012 Jul 2. J Biomed Biotechnol. 2012. PMID: 22811597 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
- R01 DK072408/DK/NIDDK NIH HHS/United States
- R01 DK072408-01A1/DK/NIDDK NIH HHS/United States
- P20 RR017659/RR/NCRR NIH HHS/United States
- R01 HL026371/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous